G01N 2800/302
Schizophrenia
G01N2800/302 (Schizophrenia) appears on 99 US grants and 226 published applications in this corpus.
Search patents in G01N- Granted patents
- 99
- Published applications
- 226
- Assignees
- 121
- Inventors
- 389
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1995 | 2 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 2 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 2 |
| 2003 | 0 | 11 |
| 2004 | 1 | 7 |
| 2005 | 1 | 8 |
| 2006 | 1 | 6 |
| 2007 | 0 | 3 |
| 2008 | 3 | 12 |
| 2009 | 1 | 9 |
| 2010 | 4 | 9 |
| 2011 | 8 | 11 |
| 2012 | 3 | 15 |
| 2013 | 3 | 12 |
| 2014 | 7 | 21 |
| 2015 | 3 | 16 |
| 2016 | 6 | 9 |
| 2017 | 7 | 19 |
| 2018 | 5 | 11 |
| 2019 | 10 | 9 |
| 2020 | 7 | 12 |
| 2021 | 5 | 2 |
| 2022 | 5 | 6 |
| 2023 | 8 | 5 |
| 2024 | 1 | 5 |
| 2025 | 3 | 3 |
| 2026 | 1 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Diagnostic methods for neural disorders15 Sep 2026US 12,736,528 B2Quiver Holdings Inc.
- Biomarkers for bipolar disorder and schizophrenia2 Sep 2025US 12,404,553 B2Laguna Diagnostics, LLC
- Exosome assay for depression and psychosis and methods and agents for treating depression, psychosis and schizophrenia29 Jul 2025US 12,372,538 B2
- Redox probing for chemical information8 Jul 2025US 12,352,720 B2University of Maryland, Baltimore
- Basal ganglia-on-chip for screening therapeutic agents for brain and nervous system diseases16 Apr 2024US 11,959,909 B2Sogang University Research Foundation
- Schizophrenia biomarker and method of diagnosis and kit of parts17 Sep 2026US 2026/0275418 A1Universidad AndréS Bello
- Extracellular vesicles, isolation and use as biomarkers16 Jul 2026US 2026/0201469 A1The University of Newcastle
- Genomic alterations associated with schizophrenia and methods of use thereof for the diagnosis and treatment of the same22 Jan 2026US 2026/0022420 A1The Children’s Hospital of Philadelphia
- Biomarkers for bipolar disorder and schizophrenia11 Dec 2025US 2025/0376731 A1Laguna Diagnostics, LLC
- Determining subtypes of schizophrenia in a subject, treatment of schizophrenia, medicament for treating schizophrenia and determining the efficacy of such medication25 Sep 2025US 2025/0295322 A1National Institute of Mental Health
Most cited
By later US patents
- Method of treating psychosis and/or hyperactivity54US 6,013,621 AThe Rockfeller University · 2000
- Methods and biomarkers for diagnosing and monitoring psychotic disorders26US 7,981,684 B2Psynova Neurotech Ltd. · 2011
- Protofibril-binding antibodies and their use in therapeutic and diagnostic methods for Parkinson's disease, dementia with lewy bodies and other α-synucleinopathies21US 8,632,776 B2BioArctic Neuroscience AB · 2014
- Antibodies to risperidone and use thereof19US 9,664,700 B2Janssen Pharmaceutica NV · 2017
- Antibodies to risperidone haptens and use thereof18US 9,751,953 B2Janssen Pharmaceutica NV · 2017